Ceramide accumulation precedes caspase-3 activation during apoptosis of A549 human lung adenocarcinoma cells

被引:66
作者
Ravid, T [1 ]
Tsaba, A [1 ]
Gee, P [1 ]
Rasooly, R [1 ]
Medina, EA [1 ]
Goldkorn, T [1 ]
机构
[1] Univ Calif Davis, Sch Med, Dept Internal Med, Ctr Comparat Resp Biol & Med, Davis, CA 95616 USA
关键词
Bcl-2; overexpression; hydrogen peroxide; sphingolipid signaling;
D O I
10.1152/ajplung.00172.2002
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Ceramide, the basic structural unit of sphingolipids, controls the balance between cell growth and death by inducing apoptosis. We have previously shown that accumulation of ceramide, triggered by hydrogen peroxide (H2O2) or by short-chain ceramide analogs, induces apoptosis of lung epithelial cells. Here we elucidate the link between caspase-3 activation, at the execution phase, and ceramide accumulation, at the commitment phase of apoptosis in A549 human lung adenocarcinoma cells. The induction of ceramide accumulation by various triggers of ceramide generation, such as H2O2, C-6-ceramide, or UDP-glucose-ceramide glucosyltransferase inhibitor DL-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol, triggered the activation of caspase-3. This ceramide elevation also induced the cleavage of the death substrate poly( ADP-ribose) polymerase and was followed by apoptotic cell death. Ceramide-mediated apoptosis was blocked by a general caspase inhibitor, Boc-D-fluoro-methylketone, and by overexpression of the antiapoptotic protein Bcl-2. Notably, overexpression of Bcl-2 reduced the basal cellular levels of ceramide and prevented the induction of ceramide generation by C-6-ceramide, which implies ceramide generation as a possible target for the antiapoptotic effects of Bcl-2.
引用
收藏
页码:L1082 / L1092
页数:11
相关论文
共 36 条
[1]   The Bcl-2 protein family: Arbiters of cell survival [J].
Adams, JM ;
Cory, S .
SCIENCE, 1998, 281 (5381) :1322-1326
[2]   Influence of Bcl-2 overexpression on the ceramide pathway in daunorubicin-induced apoptosis of leukemic cells [J].
Allouche, M ;
Bettaieb, A ;
Vindis, C ;
Rousse, A ;
Grignon, C ;
Laurent, G .
ONCOGENE, 1997, 14 (15) :1837-1845
[3]   Human ICE/CED-3 protease nomenclature [J].
Alnemri, ES ;
Livingston, DJ ;
Nicholson, DW ;
Salvesen, G ;
Thornberry, NA ;
Wong, WW ;
Yuan, JY .
CELL, 1996, 87 (02) :171-171
[4]   Ceramide-induced apoptosis occurs independently of caspases and is decreased by leupeptin [J].
Belaud-Rotureau, MA ;
Lacombe, F ;
Durrieu, F ;
Vial, JP ;
Lacoste, L ;
Bernard, P ;
Belloc, F .
CELL DEATH AND DIFFERENTIATION, 1999, 6 (08) :788-795
[5]   CERAMIDE SYNTHASE MEDIATES DAUNORUBICIN-INDUCED APOPTOSIS - AN ALTERNATIVE MECHANISM FOR GENERATING DEATH SIGNALS [J].
BOSE, R ;
VERHEIJ, M ;
HAIMOVITZFRIEDMAN, A ;
SCOTTO, K ;
FUKS, Z ;
KOLESNICK, R .
CELL, 1995, 82 (03) :405-414
[6]   Ceramide path in human lung cell death [J].
Chan, C ;
Goldkorn, T .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2000, 22 (04) :460-468
[7]   Inhibition of caspase activity prevents anti-IgM induced apoptosis but not ceramide generation in WEHI 231 B cells [J].
Chen, LJ ;
Kim, TJ ;
Pillai, S .
MOLECULAR IMMUNOLOGY, 1998, 35 (04) :195-205
[8]   Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-alpha: CrmA and Bcl-2 target distinct components in the apoptotic pathway [J].
Dbaibo, GS ;
Perry, DK ;
Gamard, CJ ;
Platt, R ;
Poirier, GG ;
Obeid, LM ;
Hannun, YA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (03) :481-490
[9]   Distinct sites of action of Bcl-2 and Bcl-xL in the ceramide pathway of apoptosis [J].
El-Assaad, W ;
El-Sabban, M ;
Awaraji, C ;
Abboushi, N ;
Dbaibo, GS .
BIOCHEMICAL JOURNAL, 1998, 336 :735-741
[10]  
GOLDKORN T, 1991, J BIOL CHEM, V266, P16092